Ignite Creation Date:
2024-05-05 @ 9:36 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006395
Status:
COMPLETED
Last Update Posted:
2008-03-04
First Post:
2000-10-07
Brief Title:
Drug Interaction Study of Tegretol Carbamazepine and St Johns Wort in Normal Volunteers
Sponsor:
National Institutes of Health Clinical Center CC
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Evaluation of the Effect of St Johns Wort on Single Dose Carbamazepine Pharmacokinetics in Normal Healthy Volunteers
Status:
COMPLETED
Status Verified Date:
2000-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
St Johns Wort is a popular dietary supplement that many patients-including those with epilepsy or seizures-take in addition to their regular medicines to elevate mood or relieve stress Preliminary research indicates that this supplement can speed the metabolism of the anti-seizure drug Tegretol causing reduced blood levels of the drug Patients who take Tegretol to control their seizures may have more frequent seizures if the blood level of the drug drops too low A recent study shows that this effect is not seen when Tegretol is taken for at least 3 weeks The present study will examine whether there is a medically important drug interaction between St Johns wort and Tegretol when Tegretol is taken for 1 day
Normal healthy volunteers between 21 and 65 years old who are not taking medicines that can affect the metabolism of drugs in the liver and have not used St Johns wort for at least 30 days may be eligible for this 25-day study
Participants will take a 400-mg dose of Tegretol after fasting overnight Blood samples will be drawn the next day during a 12-hour clinic stay at the following intervals just before the Tegretol dose and at 1 2 4 6 8 10 24 34 48 and 72 hours after the dose A catheter will be placed in the vein to prevent the need for multiple needle sticks until after the 10-hour sample After completing the blood sampling participants will take 300 mg of St Johns wort 3 times a day with meals for 2 weeks After 2 weeks another fasting dose of Tegretol will be given and the 72-hour blood study will be repeated
This study may provide information important for the care of patients with epilepsy who take both Tegretol and St Johns Wort
Normal healthy volunteers between 21 and 65 years old who are not taking medicines that can affect the metabolism of drugs in the liver and have not used St Johns wort for at least 30 days may be eligible for this 25-day study
Participants will take a 400-mg dose of Tegretol after fasting overnight Blood samples will be drawn the next day during a 12-hour clinic stay at the following intervals just before the Tegretol dose and at 1 2 4 6 8 10 24 34 48 and 72 hours after the dose A catheter will be placed in the vein to prevent the need for multiple needle sticks until after the 10-hour sample After completing the blood sampling participants will take 300 mg of St Johns wort 3 times a day with meals for 2 weeks After 2 weeks another fasting dose of Tegretol will be given and the 72-hour blood study will be repeated
This study may provide information important for the care of patients with epilepsy who take both Tegretol and St Johns Wort
Detailed Description:
Alternative or complementary therapies are widely used by patients with epilepsy St Johns Wort is one of the most popular herbal dietary supplements with a variety of claims including mood elevation and stabilization stress relief anti-viral effects and enhancement of the immune system We have previously demonstrated that treatment with St Johns Wort for 14 days does not induce the clearance of carbamazepine under steady state conditions of autoinduction of carbamazepine clearance One proposed mechanism for this lack of effect is that St Johns Wort is not sufficiently potent to further induce previously induced CYP3A4 enzyme activity The purpose of this study is to investigate the effect of St Johns Wort on single dose carbamazepine pharmacokinetics under conditions of uninduced CYP3A4 To evaluate this potential drug interaction as well as the effect of St Johns Wort on epoxide hydrolase activity eight normal healthy subjects will be enrolled into this pharmacokinetic study Subjects will take a single 400 mg dose of carbamazepine followed by serial blood sampling over 72 hours for carbamazepine and carbamazepine epoxide plasma concentrations Subjects will then begin taking a standardized formulation of St Johns Wort three times daily with meals for two weeks Following 2 weeks of St Johns Wort subjects will then again take a single 400 mg dose of carbamazepine and have serial blood samples collected for carbamazepine and carbamazepine epoxide plasma concentrations The total carbamazepine and carbamazepine epoxide exposure AUC oral clearance CLF and maximal concentrations Cmax will be compared between treatment phases to characterize the potential drug interaction
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 01-CC-0005 | None | None | None |